Nicely timed, buys some breathing space which is good. They won't get the money for a little while though as there were a few conditions and hoops to jump through so I suspect they will use that $1m loan.
A good step in the right direction and at least they got $6.3m for it, which is more than the base value in that report that was circulated.
Ann: Admedus to divest part of Infusion business, page-16
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$17.05 |
Change
-0.300(1.73%) |
Mkt cap ! $327.7M | |||
| Open | High | Low | Value | Volume |
| $17.00 | $17.44 | $16.95 | $184.6K | 10.84K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 191 | $17.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $17.50 | 500 | 1 |
View Market Depth
| Last trade - 15.59pm 19/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |